JenaValve Appoints Janet M. Fauls As Vice President Of Regulatory Affairs

IRVINE, Calif.--(BUSINESS WIRE)--JenaValve Technology, Inc., a next-generation heart-valve technology company, committed to providing state-of-the-art transcatheter aortic valve replacement (TAVR) technologies to cardiology professionals and to the broadest spectrum of patients with aortic valve disease, today announced the appointment of veteran medical device executive Janet M. Fauls as Vice President of Regulatory Affairs.